Schizophrenia Linked to Increased Risk for Subsequent CVD Events
By Elana Gotkine HealthDay Reporter
FRIDAY, March 1, 2024 -- Schizophrenia is associated with an increased risk of subsequent cardiovascular disease (CVD) events, with the association stronger in women, according to a study published online Feb. 27 in the Journal of the American Heart Association.
Jin Komuro, M.D., from the University of Tokyo, and colleagues conducted a retrospective analysis of 4,124,508 individuals aged 18 to 75 years to assess the relationship of schizophrenia with the risk for developing CVD events. The primary end point was a composite of myocardial infarction, angina pectoris, stroke, heart failure, atrial fibrillation, and pulmonary thromboembolism.
The researchers observed 182,158 composite end points during a mean follow up of 1,288 ± 1,001 days. In both men and women, there was a significant relationship of schizophrenia with an increased risk for developing composite CVD events, and a stronger association was seen in women. After multivariable adjustment, the hazard ratio for the composite end point was 1.63 and 1.42 in women and men, respectively. For angina pectoris, heart failure, and atrial fibrillation, this sex-specific difference in the association between schizophrenia and incident CVD was consistent.
"Our results suggest a need for greater support for individuals (particularly women) with schizophrenia," the authors write. "Psychiatrists, cardiologists, and general physicians should share the findings of this study and apply them to CVD prevention, especially in women."
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019
THURSDAY, June 27, 2024 -- The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June...
hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis
THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.